SomaNautix 

For targeted, precision oncology products

OWNER

Francesca Crawford (See Profile)

Sector

Oncology

Stage

Prototyping, preclinical

Country

UK

B ionic nanoparticle technology for precision targeting of tumour cells leaving healthy cells unaffected

endoNaut can be uniquely customised with surface ligands to penetrate the blood brain barrier resulting in significant brain drug concentrations

Delivers high concentrations of drug to the interior of the target cell (enhancing potency for cell killing by over tenfold).

This information is confidential, do not share or copy.

Under evaluation at least till: 20 April 2018.

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar